ASSOCIATION OF THE POLYMORPHIC INTRON 3 16 BP DUPLICATION IN TP53 (RS17878362) WITH A LOW Δ40P53:P53 RATIO AND BETTER OUTCOME IN BREAST CANCER

被引：0
|
作者：
Morten, Brianna [1 ,2 ]
Wong-Brown, Michelle [1 ,2 ]
Scott, Rodney [1 ,2 ,3 ]
Avery-Kiejda, Kelly [1 ,2 ]
机构：
[1] Hunter Med Res Inst, Ctr Informat Based Med, Sydney, NSW 2305, Australia
[2] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Prior Res Ctr Canc, Callaghan, NSW 2308, Australia
[3] John Hunter Hosp, Pathol North, New Lambton Hts, NSW 2305, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP27
引用
收藏
页码：13 / 14
页数：2
相关论文
共 50 条
  • [1] The presence of the intron 3 16 bp duplication polymorphism of p53 (rs17878362) in breast cancer is associated with a low Δ40p53:p53 ratio and better outcome
    Morten, Brianna C.
    Wong-Brown, Michelle W.
    Scott, Rodney J.
    Avery-Kiejda, Kelly A.
    CARCINOGENESIS, 2016, 37 (01) : 81 - 86
  • [2] The intron 3 16 bp duplication polymorphism of p53 (rs17878362) is not associated with increased risk of developing triple-negative breast cancer
    Brianna C. Morten
    Simon Chiu
    Christopher Oldmeadow
    Jan Lubinski
    Rodney J. Scott
    Kelly A. Avery-Kiejda
    Breast Cancer Research and Treatment, 2019, 173 : 727 - 733
  • [3] The intron 3 16bp duplication polymorphism of p53 (rs17878362) is not associated with increased risk of developing triple-negative breast cancer
    Morten, Brianna C.
    Chiu, Simon
    Oldmeadow, Christopher
    Lubinski, Jan
    Scott, Rodney J.
    Avery-Kiejda, Kelly A.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (03) : 727 - 733
  • [4] A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects
    C Sagne
    V Marcel
    A Amadou
    P Hainaut
    M Olivier
    J Hall
    Cell Death & Disease, 2013, 4 : e492 - e492
  • [5] A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects
    Sagne, C.
    Marcel, V.
    Amadou, A.
    Hainaut, P.
    Olivier, M.
    Hall, J.
    CELL DEATH & DISEASE, 2013, 4 : e492 - e492
  • [6] p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression
    Reinhardt, Luiza Steffens
    Groen, Kira
    Xavier, Alexandre
    Avery-Kiejda, Kelly A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [7] Association of TP53 Intron 3, 16 bp Duplication Polymorphism With Esophageal and Gastric Cancer Susceptibility in Kashmir Valley
    Malik, Manzoor Ahmad
    Sharma, Kokil
    Goel, Shivangi
    Zargar, Showkat Ali
    Mittal, Balraj
    ONCOLOGY RESEARCH, 2010, 19 (3-4) : 165 - 169
  • [8] Expression signature of p53 status (p53 signature) for the prediction of TP53 mutation and prognosis in breast cancer.
    Ishioka, C.
    Takahashi, S.
    Ishida, T.
    Moriya, T.
    Ohuchi, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 40S - 40S
  • [9] Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer
    Costa, Sandra
    Pinto, Daniela
    Pereira, Deolinda
    Rodrigues, Helena
    Cameselle-Teijeiro, Jorge
    Medeiros, Rui
    Schmitt, Fernando
    BMC CANCER, 2008, 8 (1)
  • [10] Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis
    Hu, Zheng
    Li, Xiang
    Qu, Xincai
    He, Yungang
    Ring, Brian Z.
    Song, Enmin
    Su, Li
    CARCINOGENESIS, 2010, 31 (04) : 643 - 647
12345